Categories: Stock Market News

Biogen proposes to purchase remaining stake in Sage in $442 million deal


(Reuters) – Drugmaker Biogen (NASDAQ:BIIB) will purchase all excellent shares of Sage Therapeutics that it doesn’t already personal for $7.22 apiece, a submitting confirmed on Friday, sending the latter’s replenish 34% in prolonged commerce.

As per the submitting, Biogen has a ten.2% stake in Sage Therapeutics. The provide worth, representing a 30% premium to the inventory’s shut on Friday, values Sage’s fairness at $441.7 million, in accordance with Reuters calculations.

Biogen has been navigating a gradual pick-up in gross sales for its Alzheimer’s drug Leqembi in the US after issues over price, efficacy and negative effects.

Sage, whose shares fell 74.9% final yr, deserted the event of its drug dalzanemdor after a number of trial failures. The corporate stated in November that it’ll give attention to its postpartum melancholy drug, Zurzuvae, which it developed in partnership with Biogen.

In July, Sage additionally scrapped the event of one other neurological dysfunction drug it was growing with Biogen.

admin

Share
Published by
admin

Recent Posts

‘We’ll see closures’: The industries hit the toughest by nationwide insurance coverage hike

The price of having workers goes up this Sunday as the rise in employers' nationwide…

5 hours ago

Excessive inflation could possibly be right here to remain

Inflation is more likely to decide up due to President Donald Trump’s sweeping tariffs, and…

7 hours ago

Excessive inflation may very well be right here to remain

Inflation is prone to decide up due to President Donald Trump’s sweeping tariffs, and will…

7 hours ago

Inventory markets droop for second day operating after Trump pronounces tariffs – in worst day for indexes since COVID

Worldwide inventory markets have plummeted for the second day operating because the fallout from Donald…

7 hours ago

JPMorgan turns into the primary Wall Avenue financial institution to forecast a US recession following Trump’s tariffs

JPMorgan believes the US financial system will enter a recession within the again half of…

8 hours ago

US Treasuries Acquire as Commerce Struggle Spurs Inflation and Development Angst

(Bloomberg) -- Treasuries climbed because the fallout from President Donald Trump’s tariffs convulsed markets for…

9 hours ago